Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy. [electronic resource]
Producer: 20111109Description: 1719-25 p. digitalISSN:- 1468-2060
- Adalimumab
- Adult
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents -- adverse effects
- Antiviral Agents -- therapeutic use
- Arthritis, Rheumatoid -- complications
- Etanercept
- Female
- Hepatitis B Antibodies -- blood
- Hepatitis B Surface Antigens -- blood
- Hepatitis B virus -- isolation & purification
- Hepatitis B, Chronic -- complications
- Humans
- Immunoglobulin G -- adverse effects
- Immunosuppressive Agents -- adverse effects
- Lamivudine -- therapeutic use
- Male
- Middle Aged
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Retrospective Studies
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- Viral Load
- Virus Activation -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.